Delhi High Court Examines Disclosure and Efficacy in Pharmaceutical Patents
The Delhi High Court's ruling in Intra Cellular Therapies v. Controller of Patents revisited critical issues regarding disclosure in pharmaceutical patents, specifically addressing the therapeutic efficacy threshold under Section 3(d) of the Patents Act.